Differential Diagnoses for Postmenstrual Bleeding
Postmenstrual bleeding (bleeding after menses) requires systematic evaluation based on the PALM-COEIN classification system, with structural causes (polyps, adenomyosis, leiomyomas, malignancy) and non-structural causes (coagulopathy, ovulatory dysfunction, endometrial disorders, iatrogenic) being the primary differentials 1.
Structural Causes (PALM)
Endometrial and Intracavitary Lesions
- Endometrial polyps - Among the most common benign causes, particularly in reproductive-age women 1
- Endometrial hyperplasia - Can present with irregular bleeding patterns
- Endometrial cancer - Critical to exclude, especially in perimenopausal women or those with risk factors (obesity, chronic anovulation) 2
- Submucosal leiomyomas - Distort the endometrial cavity and cause irregular bleeding 2
Myometrial Pathology
- Adenomyosis - Common structural cause in premenopausal women 3
- Intramural or subserosal leiomyomas - Depending on size and location 3
Cervical and Lower Tract
- Cervical polyps - Easily visualized on examination 2
- Cervical erosion or cervicitis 2
- Cervical malignancy - Must be excluded with appropriate screening 4
Non-Structural Causes (COEIN)
Coagulopathy
- Von Willebrand disease - More common than typically recognized; screen all adolescents with menorrhagia and women who fail medical/surgical therapy 2
- Other bleeding disorders - Platelet dysfunction, factor deficiencies 2
Ovulatory Dysfunction
- Anovulation - Leads to irregular endometrial shedding
- Polycystic ovary syndrome 5
- Hypothalamic dysfunction - From stress, weight changes, excessive exercise 5
Endometrial Disorders
- Dysfunctional uterine bleeding - Diagnosis of exclusion when no organic cause identified 2
- Endometritis - Infectious/inflammatory causes 2
Iatrogenic
- Hormonal contraceptives - Particularly low-dose OCPs causing breakthrough bleeding 5
- Intrauterine devices 2
- Anticoagulants 2
- Other medications - Hypothalamic depressants, digitalis, phenytoin 2
Systemic Disease
- Hypothyroidism - Check TSH in all patients 1
- Hyperprolactinemia - Measure prolactin levels 1
- Liver disease/cirrhosis 2
Critical Clinical Pearls
Age-specific considerations are paramount:
- Reproductive age women: Assume pregnancy-related until proven otherwise 2
- Perimenopausal/postmenopausal women: Assume malignancy until proven otherwise 2
- Adolescents with menorrhagia: Assume coagulopathy until proven otherwise 2
Common Pitfalls to Avoid
The term "postmenstrual bleeding" can be ambiguous - clarify whether this means:
- Bleeding immediately after normal menses (intermenstrual bleeding)
- Bleeding in the postmenopausal period (>12 months after last period)
For intermenstrual bleeding in reproductive-age women, structural and inflammatory lesions are most likely 5. If the patient uses OCPs, consider noncompliance or inadequate estrogen dosing 5.
For true postmenopausal bleeding, benign causes (atrophic endometrium, cervicitis, polyps) are more common than malignancy, but endometrial cancer accounts for approximately 10% of cases and must be excluded 4, 6.
Transvaginal ultrasound showing endometrial thickness ≤4 mm in postmenopausal women has a 99% negative predictive value for endometrial cancer 3, 6. However, in premenopausal women, endometrial thickness is NOT a reliable indicator of pathology - polyps and other lesions can be present even with thickness <5 mm 3.